Ignite Creation Date:
2025-12-24 @ 10:04 PM
Ignite Modification Date:
2026-03-06 @ 6:37 PM
Study NCT ID:
NCT04514835
Status:
UNKNOWN
Last Update Posted:
2021-08-25
First Post:
2020-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ⅱ Trials of Sintilimab as Consolidation Therapy After Radical Concurrent Chemoradiotherapy in Locally Advanced Unresectable ESCC
Sponsor:
The First Affiliated Hospital of Zhengzhou University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Esophageal Squamous Cell Carcinoma | View |
Keywords: